Biotech & MedTech News
-
DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification
April 16, 2024 (Source) — Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider…
-
FendX Technologies to Participate at Upcoming Capital Events Management Investor Conference and Provides Corporate Update
April 16, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
April 9, 2024 (Source) — DIAGNOS Inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence…
-
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors
April 3, 2024 (Source) — Voyageur Pharmaceuticals Ltd (TSXV:VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), a provider of innovative…
-
Zentek Announces U.S. Distribution Agreement for ZenGUARDTM-Enhanced Surgical Masks with Medwell Solutions
April 3, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company,…
-
DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors
April 2, 2024 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
-
Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor’s Distinguished Research Award
April 2, 2024 (Source) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing…
-
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
March 26, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”), announces that…
-
FendX Technologies Announces Second Closing of Non-Brokered Private Placement and Announces Further Upsizing to $2 million
March 25, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology…
-
Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA
March 25, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), announces that its wholly-owned subsidiary Triera…